SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-17-329703
Filing Date
2017-11-01
Accepted
2017-11-01 17:26:55
Documents
2
Group Members
ALLERGAN EQUICO B.V.ALLERGAN HOLDINGS B1, INC.ALLERGAN W.C. HOLDING INC.ALLERGAN WC HOLDINGS IRELAND LTD (FORMERLY KNOWN AS WARNER CHILCOTT PLC)WARNER CHILCOTT LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d442321dsc13da.htm SC 13D/A 141712
2 EX-1 d442321dex1.htm EX-1 12476
  Complete submission text file 0001193125-17-329703.txt   156248
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Subject) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-55457 | Film No.: 171170010
SIC: 2834 Pharmaceutical Preparations

Mailing Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400
Business Address CLONSHAUGH BUSINESS AND TECHNOLOGY PARK COOLOCK, DUBLIN L2 D17 E400 (216) 523-5000
Allergan plc (Filed by) CIK: 0001578845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations